Affimed (Nasdaq: AFMD) is a clinical stage biopharmaceutical company which engineers targeted immunotherapies, seeking to improve patient outcomes through the power of innate immunity. Affimed’s fit-for-purpose ROCK® platform allows innate immune engagers to be designed for specific patient populations. We are developing single and combination therapies to treat cancers.
To strengthen our highly motivated Translational Immunobiology Department in Heidelberg, Germany, we are looking for a
(Reference No. R2224)
For any queries, please contact Susanne Hering (Tel: 06221 6743 675, e-mail: email@example.com).
We are looking forward to receive your application including motivation letter and salary expectations.